Summer 2012 - Western University of Health Sciences

Faculty Promotions
Arezoo Campbell
was promoted to
Associate Professor of
Pharmaceutical Sciences
Sheryl Chow
was promoted to
Associate Professor of
Pharmacy Practice and
Administration
Karl Hess
was promoted to
Associate Professor of
Pharmacy Practice and
Administration
Ying Huang
was promoted to
Associate Professor of
Pharmaceutical Sciences
Anandi Law
was promoted to
Professor of Pharmacy
Practice and
Administration
Kabir Lutfy
was promoted to
Professor of
Pharmaceutical Sciences
Grants & Contracts
Doreen Pon
• WesternU ASHP/CSHP Cancer Awareness
Community Service project was awarded
$5,000 from the California Dialogue on
Cancer Program
Ying Huang and Maria Lambros
• “In vivo Evaluation of MTD and
Pharmacokinetics of Nex-Gem-0, Nex-Gem-
2 and Ne-Herceptin” from FULGENT
Therapeutics Inc. This project will last six
months with a total budget of $78,844
Ying Huang
• “Anticancer efficacy for novel formulations
of gemcitabine, COH-29 and trastuzumab in
mice” Fulgent Therapeutics, $118,096 for a
1-year period
Olivia Phung
• “The Use of Indirect Statistical Comparisons
in Evidence-based Practice Center (EPC)
Reports” from University of Connecticut,
$14,012 for a 9-month period
• “Early Combination Therapy for the
Treatment of Type 2 Diabetes Mellitus:
Systematic Review and Meta-Analysis” from
Merck, $30,000 for a 6-month period
Publications
Johnson A, Le IP, Andresen BT, Stodola J,
Dewey GL, Dean SB, Resau J, Haak P, Ruch T,
Sartor A, Lazdins I, Barney CC, and
Burnatowska Hledin MA. VACM-1/cul5
expression in vascular tissue in vivo is induced
by water deprivation and its expression in vitro
regulates aquaporin-1 concentrations. Cell
Tissue Res. 2012 DOI 10.1007/s00441-012-
1419-3 (co-first author with AEJ and IPL)
Campbell A, Cassee F, Boere A, McLean S,
Duffin R, Krystek P, Gosens I, Miller M,
“The biological effects of subacute inhalation
of diesel exhaust following addition of cerium
oxide nanoparticles in atherosclerosis-prone
mice” Environ Res. 2012 Apr 14.
Chow S. 2012 ACCP Updates in Therapeutics
Preparatory Course for BCPS (April 27-May 1)
Cardiology I. update for ADHF, atrial and
ventricular arrhythmias, pulmonary arterial
hypertension, and hypertensive emergency.
http://www.accp.com/meetings/ut12/schedule.a
spxmode=detail&i=2452
Chow S. Cardiology I. In: Dugan J, El-Iibrary
S, Foote EF, et al. Updates in Therapeutics: The
Pharmacotherapy Preparatory Review and
Recertification Course, 2012 ed. Lenexa, KS:
American College of Clinical Pharmacy, 2012.
Chow S, Finks SW, Airee A, Macaulay TE,
Moranville M, Rogers KC, Trujillo TC. “Key
Articles of Dietary Intervention that Influence
Cardiovascular Mortality.” Pharmacotherapy
2012;32(4):e54-e87.
Hata M. and the CORE (Community Pharmacy
Research and Education) “Advance community
pharmacy practice to improve patient outcomes
and pharmacist professional recognition.”
American Journal of Pharmaceutical Education
2012; 76 (3) Article 51.
Hoffman J, Shah D, “Pain Management in the
Elderly.” California Pharmacist. Spring 2012
Issue.
http://www.nxtbook.com/nxtbooks/naylor/PH
DQ0212/index.php#/28
Huang Y, Wang J, Liu, M. “Developing
Phytoestrogens for Breast Cancer Prevention.”
Anticancer Agents Med Chem. 2012 May 2.
Jackevicius CA, de Leon N. “Use of aspirin
and clopidogrel post-coronary artery bypass
graft surgery”Ann Pharmacother 2012; DOI
10.1345/aph.1Q692
Jackevicius CA, Ionescu-Ittu, Abrahamowicz
M, Essebag V, Pilote L,. “Comparative
effectiveness of rhythm control vs. rate control
drug treatment effect on mortality in patients
with atrial fibrillation.” Arch Intern Med
2012; DOI 10.1345/aph.1Q692
Jackevicius CA, Tsadok MA, Rahme E,
Humphries KH, Behlouli H, Pilote L. “Sex
differences in stroke risk among older patients
with recently diagnosed atrial fibrillation.”
JAMA 2012;307:1952-8.
Jackevicius CA, Psaty B, Redberg R, “Evidence
of Pharmaceutical Innovation and Therapeutic
Enthusiasm: Strategies for Patent Extension”
Arch Intern Med Published online April 9,
2012 http://archinte.ama-assn.org/cgi/content/
full/archinternmed.2012.382etoc
Jackevicius CA, Downing N, Ross J, Krumholz
H. “Avoidance of Generic Competition by
Abbott Laboratories’ Fenofibrate Franchise”
Arch Intern Med Published online April 9,
2012. http://archinte.ama-assn.org/cgi/content/
abstract/archinternmed.2012.187etoc
Jackevicius CA, Ross JS, Krumholz HM,
Ridgeway JL, Montori VM, Alexander GC,
Zerzan JT, Fan J, Shah ND. “State Medicaid
programs did not make use of prior
authorization to promote safer prescribing
after rosiglitazone warnings.” Health Affairs
2012;31:188-98.
Khasawneh F, Espinosa E.V.P., Murad J.P.,
Ting H.J., “Mouse Transient Potential Channel
6: Role in Hemostasis and Thrombogenesis,”
Biochem Biophys Res Commun., 2011 Dec 20.
WesternU, College of Pharmacy RxBound | 31